24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
DM · Super-Speciality (Medical)

Sarcoma & Rare Tumours and Oncological Emergencies and more Thesis Topics for DM Medical Oncology — 60+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 60+ DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

60+DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 60 titles See a full thesis plan
Sarcoma & Rare Tumours and Oncological Emergencies and more thesis topics

DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) — Thesis Title List

60 titles · instant objectives
  1. 001

    Clinico-pathological profile and treatment outcome of soft tissue sarcomas at a tertiary care centre

    Sarcoma & Rare Tumours Prospective observational study Descriptive Study
    Objective
  2. 002

    Outcome of osteosarcoma and Ewing sarcoma treated with multimodality therapy in adolescents and young adults

    Sarcoma & Rare Tumours Prospective observational study Prospective Study
    Objective
  3. 003

    Clinical profile and outcome of gastrointestinal stromal tumours on imatinib

    Sarcoma & Rare Tumours Prospective observational study Prospective Study
    Objective
  4. 004

    Clinical profile and outcome of cancer of unknown primary at a tertiary care centre

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  5. 005

    Oncological emergencies at presentation: spectrum, management and outcome in a medical oncology unit

    Oncological Emergencies Prospective observational study Descriptive Study
    Objective
  6. 006

    Tumour lysis syndrome in haematological malignancies: incidence, risk factors and outcome with rasburicase

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  7. 007

    Venous thromboembolism in cancer patients: incidence, risk factors and adequacy of thromboprophylaxis using the Khorana score

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  8. 008

    Clinical profile and outcome of brain metastases from solid tumours and role of systemic therapy

    Metastatic Disease Prospective observational study Descriptive Study
    Objective
  9. 009

    Skeletal-related events in bone metastases and effect of zoledronic acid versus denosumab

    Metastatic Disease Prospective comparative study Comparative Study
    Objective
  10. 010

    Geriatric assessment and chemotherapy toxicity in elderly cancer patients using the CARG score

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  11. 011

    Treatment patterns and outcome of cancer in patients above 70 years at a tertiary oncology centre

    Geriatric Oncology Prospective observational study Descriptive Study
    Objective
  12. 012

    Clinical profile and outcome of mucosal melanoma treated with immunotherapy

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  13. 013

    Medical management and outcome of desmoid tumours

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  14. 014

    Clinical profile and outcome of rhabdomyosarcoma in adults

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  15. 015

    Clinical profile and outcome of extrapulmonary neuroendocrine carcinoma

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  16. 016

    Response to methotrexate and predictors of resistance in low-risk gestational trophoblastic neoplasia

    Sarcoma & Rare Tumours Prospective observational study Prospective Study
    Objective
  17. 017

    Response and toxicity of pazopanib in advanced soft tissue sarcoma

    Sarcoma & Rare Tumours Prospective observational study Prospective Study
    Objective
  18. 018

    Clinical profile and outcome of adrenocortical carcinoma treated with mitotane

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  19. 019

    Clinicopathological profile and outcome of uterine sarcomas

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  20. 020

    Etiology of hypercalcaemia of malignancy and response to zoledronic acid versus denosumab

    Oncological Emergencies Prospective comparative study Comparative Study
    Objective
  21. 021

    Time to treatment and ambulatory outcome in malignant spinal cord compression

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  22. 022

    Clinical profile and outcome of superior vena cava syndrome in malignancy

    Oncological Emergencies Prospective observational study Descriptive Study
    Objective
  23. 023

    Empirical antibiotic choice, carbapenem resistance and outcome in febrile neutropenia in solid tumours

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  24. 024

    Clinical profile and outcome of neutropenic enterocolitis

    Oncological Emergencies Retrospective record-based study Descriptive Study
    Objective
  25. 025

    Incidence and risk factors of acute kidney injury with cisplatin and high-dose methotrexate

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  26. 026

    Management and outcome of malignant bowel obstruction in advanced cancer

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  27. 027

    Incidence and outcome of hyponatraemia due to SIADH in small cell lung cancer

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  28. 028

    Local consolidative therapy in oligometastatic non-small cell lung cancer: progression-free survival

    Metastatic Disease Prospective comparative study Comparative Study
    Objective
  29. 029

    Intracranial response to osimertinib in EGFR-mutant non-small cell lung cancer with brain metastases

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  30. 030

    Conversion chemotherapy and resectability of colorectal liver metastases

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  31. 031

    Clinical profile and outcome of leptomeningeal metastases from solid tumours

    Metastatic Disease Retrospective record-based study Descriptive Study
    Objective
  32. 032

    Clinical profile and management outcome of malignant ascites

    Metastatic Disease Prospective observational study Descriptive Study
    Objective
  33. 033

    Patterns of metastasis by molecular subtype in metastatic breast cancer

    Metastatic Disease Retrospective record-based study Descriptive Study
    Objective
  34. 034

    Outcome of palliative chemotherapy in patients with poor performance status (ECOG 2 or more)

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  35. 035

    Prognostic nutritional index and survival in patients with metastatic solid tumours

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  36. 036

    G8 screening tool versus comprehensive geriatric assessment in elderly patients with cancer

    Geriatric Oncology Prospective observational study Diagnostic Study
    Objective
  37. 037

    Polypharmacy and potentially inappropriate medications in elderly patients receiving cancer treatment

    Geriatric Oncology Hospital-based cross-sectional study Cross-sectional Study
    Objective
  38. 038

    Toxicity and outcome of dose-reduced chemotherapy in patients aged 70 years and above

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  39. 039

    Frailty and outcome of immune checkpoint inhibitors in elderly patients with cancer

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  40. 040

    Prevalence of cognitive impairment in elderly patients with cancer before chemotherapy

    Geriatric Oncology Hospital-based cross-sectional study Cross-sectional Study
    Objective
  41. 041

    Falls and functional decline during chemotherapy in elderly patients with cancer

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  42. 042

    Clinical profile and outcome of acral lentiginous melanoma treated with immune checkpoint inhibitors

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  43. 043

    Clinicopathological profile and outcome of retroperitoneal soft tissue sarcomas at a tertiary care centre

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  44. 044

    Incidence and risk factors of tumour lysis syndrome in solid tumours after initiation of first-line systemic therapy

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  45. 045

    Validation of a clinical risk score for prediction of cisplatin-associated acute kidney injury in adults with solid tumours

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  46. 046

    Clinical profile and outcome of life-threatening immune-related adverse events requiring intensive care admission

    Oncological Emergencies Retrospective record-based study Descriptive Study
    Objective
  47. 047

    Outcome of local ablative therapy for oligoprogressive disease while continuing targeted therapy in metastatic solid tumours

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  48. 048

    Prognostic value of the systemic immune-inflammation index in metastatic colorectal cancer on first-line chemotherapy

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  49. 049

    Tumour lysis syndrome and acute kidney injury risk in patients with metastatic cancer and pre-existing chronic kidney disease

    Metastatic Disease Hospital-based cross-sectional study Cross-sectional Study
    Objective
  50. 050

    Clinical Frailty Scale as a predictor of chemotherapy completion, grade 3 or higher toxicity and unplanned hospitalisation in patients aged 65 years and above

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  51. 051

    Effect of geriatric assessment-guided treatment modification on chemotherapy toxicity in older adults with solid tumours

    Geriatric Oncology Prospective comparative study Comparative Study
    Objective
  52. 052

    Nutritional risk by Mini Nutritional Assessment and its association with treatment tolerance in elderly patients with cancer

    Geriatric Oncology Hospital-based cross-sectional study Cross-sectional Study
    Objective
  53. 053

    Respiratory viral infections on multiplex PCR in febrile neutropenia among adults with haematological malignancies and their effect on outcome

    Oncological Emergencies Prospective observational study Prospective Study
    Objective
  54. 054

    Procalcitonin versus high-sensitivity CRP for predicting bacteraemia and adverse outcome in febrile neutropenia in adults with acute leukaemia

    Oncological Emergencies Prospective observational study Diagnostic Study
    Objective
  55. 055

    Intrathecal pemetrexed in leptomeningeal metastases from non-small cell lung cancer: CSF cytological clearance, clinical response and myelosuppression

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  56. 056

    Quality of life and neurocognitive function after whole-brain radiotherapy in patients with brain metastases from solid tumours

    Metastatic Disease Prospective observational study Prospective Study
    Objective
  57. 057

    Short Physical Performance Battery score and its association with grade 3 or higher chemotherapy toxicity in older adults with cancer

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  58. 058

    Prevalence of sarcopenia by handgrip strength and SARC-F and its association with treatment completion in older adults starting chemotherapy

    Geriatric Oncology Prospective observational study Prospective Study
    Objective
  59. 059

    Clinicopathological profile, serum inhibin and outcome of adult granulosa cell tumours of the ovary

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective
  60. 060

    Clinical profile, systemic therapy and outcome of ultra-rare sarcomas including alveolar soft part sarcoma at a tertiary cancer centre

    Sarcoma & Rare Tumours Retrospective record-based study Descriptive Study
    Objective

DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) thesis — frequently asked questions

How many DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) thesis topics are listed here?

60+ DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) thesis topics are listed on this page, organised by subsection of the Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, DM and FCPS Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) candidates?

Yes — these Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) dissertation titles are aligned with NMC, NBE and DNB Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) curricula and are suitable for DM Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more), DNB Medical Oncology (Sarcoma & Rare Tumours and Oncological Emergencies and more) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp